JAMES W. SMITH, M.D.; STEPHEN R. JONES, M.D.; WILLIAM P. REED, M.D.; ALAN D. TICE, M.D.; ROBERT H. DEUPREE, Ph.D.; BERTIL KAIJSER, M.D.
All men with recurrent urinary tract infections entered into a study had a positive antibody-coated bacteria test, and 52% had evidence for prostate infection. Escherichia coli infection was present in 74% and urinary tract symptoms in 57% of those randomized. Thirty-eight patients were randomized in a double-blind clinical trial to receive either 10 d of treatment with trimethoprim/sulfamethoxazole or a 12-week course of the drug. The cure rate in patients receiving 12 weeks of therapy (nine of 15) was higher than that in patients receiving a single 10-d course (three of 15); difference was marginally significant (P = 0.06). Recurrences were usually with the same organism, and most (78%) occurred within 4 weeks of discontinuing therapy. This study indicates that a standard 10-d course of therapy usually fails to cure men with recurrent urinary tract infections with a positive antibody-coated bacteria test.
SMITH JW, JONES SR, REED WP, TICE AD, DEUPREE RH, KAIJSER B. Recurrent Urinary Tract Infections in Men: Characteristics and Response to Therapy. Ann Intern Med. ;91:544–548. doi: 10.7326/0003-4819-91-4-544
Download citation file:
Published: Ann Intern Med. 1979;91(4):544-548.
Infectious Disease, Nephrology, Urinary Tract Infection, Urological Disorders.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use